Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Migräne-Echtroplex is a homeopathic complex medicine developed by Weber & Weber Biologische Arzneimittel for the treatment of migraine and migraine-like headaches. It contains a combination of natural active ingredients including *Cyclamen purpurascens* (sowbread), *Gelsemium sempervirens* (yellow jasmine), *Iris versicolor* (blue flag), and *Sanguinaria canadensis* (bloodroot). These components are traditionally used in homeopathy to address various symptoms associated with migraines, such as visual disturbances, unilateral pain, and nausea. As a homeopathic remedy, its mechanism of action is based on the principle of "like cures like" and the use of highly diluted substances to stimulate the body's self-healing processes. It is registered in Germany as a pharmaceutical product for the relief of migraine symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Migräne-Echtroplex.